Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 19

    1.

    High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates.

    Verheyen J, Verhofstede C, Knops E, Vandekerckhove L, Fun A, Brunen D, Dauwe K, Wensing A, Pfister H, Kaiser R, Nijhuis M.

    AIDS. 2009 Nov 18. [Epub ahead of print]PMID: 19926962 [PubMed - as supplied by publisher]Related articles

    2.

    Comparison of the Generic HIV Viral Load((R)) assay with the Amplicor HIV-1 Monitor v1.5 and Nuclisens HIV-1 EasyQ((R)) v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: The Kesho Bora preparatory study.

    Rouet F, Foulongne V, Viljoen J, Steegen K, Becquart P, Valéa D, Danaviah S, Segondy M, Verhofstede C, Van de Perre P; for the WHO/ANRS 1289 Kesho Bora Study Group.

    J Virol Methods. 2009 Oct 27. [Epub ahead of print]PMID: 19837114 [PubMed - as supplied by publisher]Related articles

    3.

    Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya.

    Steegen K, Luchters S, Dauwe K, Reynaerts J, Mandaliya K, Jaoko W, Plum J, Temmerman M, Verhofstede C.

    AIDS Res Ther. 2009 Jun 16;6:12.PMID: 19531211 [PubMed - in process]Related articlesFree article

    4.

    Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients.

    Vandekerckhove L, Verhofstede C, Vogelaers D.

    J Antimicrob Chemother. 2009 Jun;63(6):1087-96. Epub 2009 Apr 18.PMID: 19377064 [PubMed - indexed for MEDLINE]Related articles

    5.

    CXCR4-using HIV type 1 variants are more commonly found in peripheral blood mononuclear cell DNA than in plasma RNA.

    Verhofstede C, Vandekerckhove L, Eygen VV, Demecheleer E, Vandenbroucke I, Winters B, Plum J, Vogelaers D, Stuyver L.

    J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):126-36.PMID: 19131897 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains.

    Chalmet K, Van Wanzeele F, Demecheleer E, Dauwe K, Pelgrom J, Van Der Gucht B, Vogelaers D, Plum J, Stuyver L, Vandekerckhove L, Verhofstede C.

    Virology. 2008 Sep 30;379(2):213-22. Epub 2008 Aug 9.PMID: 18692212 [PubMed - indexed for MEDLINE]Related articles

    7.

    Maraviroc: integration of a new antiretroviral drug class into clinical practice.

    Vandekerckhove L, Verhofstede C, Vogelaers D.

    J Antimicrob Chemother. 2008 Jun;61(6):1187-90. Epub 2008 Apr 9.PMID: 18400807 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.

    Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Deforche K, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, van den Heuvel A, van der Gucht B, van Ranst M, van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Vandamme AM, van Laethem K.

    AIDS Res Hum Retroviruses. 2008 Mar;24(3):355-62.PMID: 18327983 [PubMed - indexed for MEDLINE]Related articles

    9.

    Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

    Ruelle J, Roman F, Vandenbroucke AT, Lambert C, Fransen K, Echahidi F, Piérard D, Verhofstede C, Van Laethem K, Delforge ML, Vaira D, Schmit JC, Goubau P.

    BMC Infect Dis. 2008 Feb 27;8:21.PMID: 18304321 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings.

    Steegen K, Luchters S, De Cabooter N, Reynaerts J, Mandaliya K, Plum J, Jaoko W, Verhofstede C, Temmerman M.

    J Virol Methods. 2007 Dec;146(1-2):178-87. Epub 2007 Aug 7.PMID: 17686534 [PubMed - indexed for MEDLINE]Related articles

    11.

    Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots.

    Steegen K, Luchters S, Demecheleer E, Dauwe K, Mandaliya K, Jaoko W, Plum J, Temmerman M, Verhofstede C.

    J Clin Microbiol. 2007 Oct;45(10):3342-51. Epub 2007 Aug 1.PMID: 17670924 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.

    Verhofstede C, Van Wanzeele F, Van Der Gucht B, Pelgrom J, Vandekerckhove L, Plum J, Vogelaers D.

    J Med Virol. 2007 Sep;79(9):1254-60.PMID: 17607772 [PubMed - indexed for MEDLINE]Related articles

    13.

    A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.

    Steegen K, Demecheleer E, De Cabooter N, Nges D, Temmerman M, Ndumbe P, Mandaliya K, Plum J, Verhofstede C.

    J Virol Methods. 2006 May;133(2):137-45. Epub 2005 Dec 20.PMID: 16375980 [PubMed - indexed for MEDLINE]Related articles

    14.

    The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance.

    Noë A, Plum J, Verhofstede C.

    J Antimicrob Chemother. 2005 Apr;55(4):410-2. Epub 2005 Feb 22. Review.PMID: 15728140 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Low efficacy of nevirapine (HIVNET012) in preventing perinatal HIV-1 transmission in a real-life situation.

    Quaghebeur A, Mutunga L, Mwanyumba F, Mandaliya K, Verhofstede C, Temmerman M.

    AIDS. 2004 Sep 3;18(13):1854-6.PMID: 15316350 [PubMed - indexed for MEDLINE]Related articles

    16.

    Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy.

    Verhofstede C, Noë A, Demecheleer E, De Cabooter N, Van Wanzeele F, Van Der Gucht B, Vogelaers D, Plum J.

    J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):473-83.PMID: 15021312 [PubMed - indexed for MEDLINE]Related articles

    17.

    Placental malaria and perinatal transmission of human immunodeficiency virus type 1.

    Inion I, Mwanyumba F, Gaillard P, Chohan V, Verhofstede C, Claeys P, Mandaliya K, Van Marck E, Temmerman M.

    J Infect Dis. 2003 Dec 1;188(11):1675-8. Epub 2003 Nov 10.PMID: 14639538 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diversity of the human immunodeficiency virus type 1 (HIV-1) env sequence after vertical transmission in mother-child pairs infected with HIV-1 subtype A.

    Verhofstede C, Demecheleer E, De Cabooter N, Gaillard P, Mwanyumba F, Claeys P, Chohan V, Mandaliya K, Temmerman M, Plum J.

    J Virol. 2003 Mar;77(5):3050-7.PMID: 12584330 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Placental inflammation and perinatal transmission of HIV-1.

    Mwanyumba F, Gaillard P, Inion I, Verhofstede C, Claeys P, Chohan V, Vansteelandt S, Mandaliya K, Praet M, Temmerman M.

    J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):262-9.PMID: 11873075 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...